Literature DB >> 18500436

Acute pseudogout after pamidronate infusion.

Daniel Wendling1, Guillaume Tisserand, Vincent Griffond, Clarisse Saccomani, Eric Toussirot.   

Abstract

A 72-year-old man, treated with a 60-mg intravenous infusion of pamidronate for shoulder hand syndrome, developed after few hours an acute pseudogout arthritis of his right knee. Diagnosis was confirmed by synovial fluid analysis and was associated with hypocalcemia. Only a few cases are reported in the literature. The mechanism of this potential side effect remains speculative.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500436     DOI: 10.1007/s10067-008-0923-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  5 in total

1.  Bisphosphonate-associated arthritis.

Authors:  Alejandro Diaz-Borjon; Thorsten M Seyler; Natasha L Chen; S Sam Lim
Journal:  J Clin Rheumatol       Date:  2006-06       Impact factor: 3.517

2.  Weekly alendronate-induced acute pseudogout.

Authors:  S A Young-Min; L Herbert; M Dick; J Fordham
Journal:  Rheumatology (Oxford)       Date:  2005-01       Impact factor: 7.580

3.  Pseudogout associated with the use of cyclical etidronate therapy.

Authors:  S J Gallacher; I T Boyle; H A Capell
Journal:  Scott Med J       Date:  1991-04       Impact factor: 0.729

4.  Acute pseudogout as a complication of pamidronate.

Authors:  S D Malnick; S Ariel-Ronen; E Evron; Z M Sthoeger
Journal:  Ann Pharmacother       Date:  1997-04       Impact factor: 3.154

Review 5.  Management of the adverse effects associated with intravenous bisphosphonates.

Authors:  T Tanvetyanon; P J Stiff
Journal:  Ann Oncol       Date:  2006-03-17       Impact factor: 32.976

  5 in total
  2 in total

1.  Incident acute pseudogout and prior bisphosphonate use: Matched case-control study in the UK-Clinical Practice Research Datalink.

Authors:  Edward Roddy; Sara Muller; Zoe Paskins; Samantha L Hider; Milisa Blagojevic-Bucknall; Christian D Mallen
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

2.  A Case of Pseudogout Following Zoledronic Acid Administration.

Authors:  Alexander C Hill; Rania Al Asmar; Adenrele A Olajide; Nesreen BenHamed
Journal:  Cureus       Date:  2021-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.